MEDIROM Healthcare Technologies Inc ADR [NASDAQ: MRM] jumped around 0.16 points on Thursday, while shares priced at $2.23 at the close of the session, up 7.73%.
MEDIROM Healthcare Technologies Inc ADR stock is now -13.23% down from its year-to-date (YTD) trading value. MRM Stock saw the intraday high of $2.29 and lowest of $2.08 per share. The company’s 52-week high price is 4.45, which means current price is +555.30% above from all time high which was touched on 09/26/25.
Compared to the average trading volume of 4.80M shares, MRM reached a trading volume of 4736048 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about MEDIROM Healthcare Technologies Inc ADR [MRM]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MRM shares is $5.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MRM stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Price to Book ratio for the last quarter was 10.48, with the Price to Cash per share for the same quarter was set at 0.03.
How has MRM stock performed recently?
MEDIROM Healthcare Technologies Inc ADR [MRM] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -13.90. With this latest performance, MRM shares gained by 6.19% in over the last four-week period, additionally plugging by 167.67% over the last 6 months – not to mention a rise of 116.50% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MRM stock in for the last two-week period is set at 49.18, with the RSI for the last a single of trading hit 0.26, and the three-weeks RSI is set at 0.28 for MEDIROM Healthcare Technologies Inc ADR [MRM]. The present Moving Average for the last 50 days of trading for this stock 2.04, while it was recorded at 2.46 for the last single week of trading, and 1.33 for the last 200 days.
MEDIROM Healthcare Technologies Inc ADR [MRM]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and MEDIROM Healthcare Technologies Inc ADR [MRM] shares currently have an operating margin of -2.59% and a Gross Margin at 24.96%. MEDIROM Healthcare Technologies Inc ADR’s Net Margin is presently recorded at 0.36%.
MEDIROM Healthcare Technologies Inc ADR (MRM) Capital Structure & Debt Analysis
According to recent financial data for MEDIROM Healthcare Technologies Inc ADR. ( MRM), the Return on Equity (ROE) stands at 48.22%, highlighting impressive shareholder gains. The Return on Assets (ROA) is 0.43%, reflecting the company’s efficiency in generating profits from its assets. Additionally, MEDIROM Healthcare Technologies Inc ADR’s Return on Invested Capital (ROIC) is 1.22%, showcasing its effectiveness in deploying capital for earnings.
MEDIROM Healthcare Technologies Inc ADR (MRM) Efficiency & Liquidity Metrics
Based on MEDIROM Healthcare Technologies Inc ADR’s (MRM) latest financial statements, the Debt-to-Equity Ratio is 8.83%, indicating its reliance on debt financing relative to shareholder equity.
MEDIROM Healthcare Technologies Inc ADR (MRM) Efficiency & Liquidity Metrics
From an operational efficiency perspective, MEDIROM Healthcare Technologies Inc ADR. (MRM) effectively leverages its workforce, generating an average of $180.78 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.24% and a Quick Ratio of 0.21%, indicating strong ability to cover short-term liabilities.
Insider trade positions for MEDIROM Healthcare Technologies Inc ADR [MRM]
There are presently around $1.48%, or 2.02%% of MRM stock, in the hands of institutional investors.
